Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2001
05/03/2001CA2386509A1 G protein-coupled receptors expressed in human brain
05/03/2001CA2385193A1 Lateral flow device utilising particulate carrier
05/02/2001EP1096258A1 Assay of proteins such as type E immunoglobulins (IgE) in nasal secretions
05/02/2001EP1096257A2 Method, device and dye labelled peptide for the detection of molecules
05/02/2001EP1096256A1 Chromatography quantitative measurement device, chromatography quantitative measurement method, and chromatography test piece used therefor
05/02/2001EP1096255A2 Method for measuring skin absorbability
05/02/2001EP1096254A2 Capillary hematocrit separation structure and method
05/02/2001EP1096251A1 Film responsive to bicarbonate ion
05/02/2001EP1096246A1 Test method and apparatus for assessing a tendency to squeak of an assembly
05/02/2001EP1096024A1 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays
05/02/2001EP1096016A1 Platelet-activating factor acetylhydrolase
05/02/2001EP1096009A1 G-protein coupled receptor-like Polypeptide
05/02/2001EP1096008A2 Human G protein-coupled receptor, PFI-014
05/02/2001EP1095694A2 Gas permeable membrane and use thereof for controlling gas passage
05/02/2001EP1095352A1 An apparatus for the enhancement of water quality in a subterranean pressurized water system
05/02/2001EP1095280A2 System for the quantification of platelet activation
05/02/2001EP1095279A1 Method for identifying a presenilinase inhibitor
05/02/2001EP1095278A2 Differential diagnosis of neurodegeneration
05/02/2001EP1095277A2 A system for cell-based screening
05/02/2001EP1095276A1 Method for diagnosing an adenocarcinoma or a benign prostate pathology
05/02/2001EP1095275A2 Endogenous constitutively activated g protein-coupled orphan receptors
05/02/2001EP1095274A1 Trifunctional reagent for conjugation to a biomolecule
05/02/2001EP1095273A1 Optical sensor for in situ measurement of analytes
05/02/2001EP1095272A1 Determination of ligands for proteins
05/02/2001EP1095271A1 Method of diagnosing cardiovascular disease and early atherosclerosis
05/02/2001EP1095270A1 Screening device and method of screening an immunoassay test
05/02/2001EP1095269A2 Device for determining the content of carbon dioxide in exhaled air
05/02/2001EP1095267A1 Method to detect and analyze tight-binding ligands in complex biological samples
05/02/2001EP1095266A1 Method and measuring arrangement for measuring gas content of fluid
05/02/2001EP1095263A1 Method for determining the quality of fruit and berries and apparatus for sorting fruit and berries
05/02/2001EP1095261A1 Method and device for fluorescence measurement
05/02/2001EP1095260A1 Process and device for the measuring of colour and/or particles in a fluid
05/02/2001EP1095255A1 Method and apparatus for locating hidden corpses by detecting volatile gas combinations
05/02/2001EP1095251A2 Method for measuring volatile organic compounds and a kit for sa me
05/02/2001EP1095205A1 Method of determining in-situ stresses in an earth formation
05/02/2001EP1095183A2 Methods for the diagnosis and treatment of lung cancer
05/02/2001EP1095161A2 Novel polycyclic aromatic fluorogenic substrates for hydrolases
05/02/2001EP1095148A2 Cloning and characterisation of novel mammalian peptidases
05/02/2001EP1095140A2 Neurotrophic factors
05/02/2001EP1095062A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands
05/02/2001EP1095060A1 Galectin 11
05/02/2001EP1095059A1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use
05/02/2001EP1095053A1 Arylsulfone linkers for mass spectrometric analysis
05/02/2001EP1095052A1 Silicon-containing linkers for nucleic acid mass markers
05/02/2001EP1095050A1 Phosphorous organic compounds and their use
05/02/2001EP1094827A1 Prion protein and uses thereof
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP1094800A2 PEPTIDYL-PROLYL $i(CIS)-TRANS ISOMERASE INHIBITORS AND USES THEREFOR
05/02/2001EP0995117A4 Systems and methods for monitoring and analyzing operation of medical processing devices
05/02/2001EP0944492A4 Capacitive sensor assembly
05/02/2001EP0882230A4 Chemiluminescent assay methods and devices for detecting target analytes
05/02/2001EP0871890A4 Rapid immunoassay for streptococcus mutans
05/02/2001EP0777691B1 Polymerisation process for the preparation of calibrated monodisperse latex in dispersion
05/02/2001EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
05/02/2001CN2428775Y Device for recovering and cleaning tested blood sample
05/02/2001CN1293760A Method for counting leukocytes and leukocyte counter
05/02/2001CN1293757A Refractometer and method for qualitative and quantitive measurements
05/02/2001CN1293204A Polypeptide-human bromo-functional protein 72 and polynucleotide for coding this polypeptide
05/02/2001CN1293203A Polypeptide-human zinc finger protein 59 and polynucleotide for coding this polypeptide
05/01/2001US6226378 Method and system for anonymously testing for a human malady
05/01/2001US6226352 System and method for radiographic imaging of tissue
05/01/2001US6225633 Photo-ionization detector for volatile gas measurement and a method for self-cleaning the same
05/01/2001US6225625 Signal detection methods and apparatus
05/01/2001US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides
05/01/2001US6225451 Chromosome 11-linked coronary heart disease susceptibility gene CHD1
05/01/2001US6225450 Intact positively charged ionized mass-modified nucleic acid molecule
05/01/2001US6225448 1gG /transferrin receptor fusion protein
05/01/2001US6225447 Methods for producing members of specific binding pairs
05/01/2001US6225442 Containing as an antigen at least one mammalian protein selected from among ezrin, radixin and moesin and/or a peptide composed of at least nine consecutive amino acid residues found in the amino acid sequences of ezrin, radixin and moesin
05/01/2001US6225296 Inhibitory effects of synthetic and natural colorant on carcinogenesis VIII
05/01/2001US6225293 Methods and compounds for tracking the biodistribution of macromolecule-carrier combinations
05/01/2001US6225286 Cell surface protein expressed on human cortical thymocyte and their use
05/01/2001US6225132 Derivatizing agent comprising a multiphoton-emitting radioisotope and a moiety that forms a non-covalent chemical bond with an analyte of interest, suitable for detection of the analyte of interest
05/01/2001US6225131 Apparatus for the detection of preferential compounds in sample
05/01/2001US6225130 Method of separating serum from whole blood
05/01/2001US6225128 Color test card package for testing for the presence of lead
05/01/2001US6225127 Detection, determination, and quantitation of certain anions involving the quenching of a fluorescent label attached to a metalloenzyme due to fluorescence energy transfer to a colored inhibitor
05/01/2001US6225126 Method and apparatus for measuring hemostasis
05/01/2001US6225124 Small amount of a predetermined nonionic surfactant added within a limited range of concentration, and of a salt for adjusting osmotic pressure of the sample
05/01/2001US6225123 Adjuvuant for utilization in body fluid recovery; for use in recovery and detection of blood products
05/01/2001US6225120 Detection of modulator of receptor protein activity; providing nematode, isolated nematode cell or mammalian cell expressing receptor activity, incubate with modulator and detect amplification in receptor activity
05/01/2001US6225118 Multicellular in vitro assay of angiogenesis
05/01/2001US6225109 Apparatus for the detection of nucleotide sequences; for the detection of restriction fragment length polymorphisms in humans; for monitoring antibiotic resistance in bacteria
05/01/2001US6225103 Protease for use as diagnostic indicator of cancer
05/01/2001US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats
05/01/2001US6225098 UDP-N-acetylenolpyruvyglucosamine reductase
05/01/2001US6225092 One step, one pot process using a second thermostable dna polymerase which has a reduced ability to incorporate dideoxynucleotides
05/01/2001US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus
05/01/2001US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis
05/01/2001US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production
05/01/2001US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries
05/01/2001US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis
05/01/2001US6225079 Microtitration unit
05/01/2001US6225073 Immunoassay for mycophenolic acid
05/01/2001US6225072 Process for the extraction of proteins
05/01/2001US6225071 Treating non-activated neutrophils with compound, exposing to activating conditions, then contacting with galectin-1; activation is inhibited when neutrophils do not agglutinate; antiinflammatory agents with reduced side effects
05/01/2001US6225070 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
05/01/2001US6225068 Simple extraction of individual fluorescent macromolecule from fluid by coating region of fiber tip with binding molecules, dipping tip into fluid, irradiating tip, removing tip when detected fluoresence exceeds predetermined intensity
05/01/2001US6225067 Methods and devices for performing analysis of a nucleic acid sample
05/01/2001US6225066 Determining drug resistance by incubating strain with drug and temperate mycobacteriophage permiting formation of lysogens which express reporter gene, then detecting transcription of reporter gene as indicator of resistance